EntrarCadastrar

/

Sunitinib

CAS 557795-19-4

Visão geral

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase inhibitor that was approved by the FDA for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor on January 26, 2006

A Anant Labs fabrica e fornece impurezas de Sunitinib de alta qualidade para o mercado global. Nossas impurezas EP de Sunitinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Chemical structure of Sunitinib

Sunitinib

CAS: 557795-19-4
Mol. Formula: C₂₂H₂₇FN₄O₂
Mol. Weight: 398.482

Impurezas (6)

Chemical structure of Sunitinib Aldehyde Impurity

Sunitinib Aldehyde Impurity

Cat. No.: ANT-SNB-005
CAS: 356068-93-4
Mol. Formula: C₁₆H₁₃FN₂O₃
Mol. Weight: 300.28

Chemical structure of Sunitinib Des-Ethyl Impurity

Sunitinib Des-Ethyl Impurity

Cat. No.: ANT-SNB-006
CAS: 356068-97-8
Mol. Formula: C₂₀H₂₃FN₄O₂
Mol. Weight: 370.42

Chemical structure of Sunitinib Malate

Sunitinib Malate

Cat. No.: ANT-SNB-01
CAS: 341031-54-7
Mol. Formula: C₂₂H₂₇FN₄O₂.C₄H₆O₅
Mol. Weight: 532.569

Chemical structure of Sunitinib Malate Impurity D

Sunitinib Malate Impurity D

Cat. No.: ANT-SNB-02
CAS: 356068-86-5
Mol. Formula: C₁₄H₂₃N₃O₂
Mol. Weight: 265.36

Chemical structure of Sunitinib Malate Impurity F

Sunitinib Malate Impurity F

Cat. No.: ANT-SNB-04
CAS: 56341-41-4
Mol. Formula: C₈H₆FNO
Mol. Weight: 151.14

Chemical structure of Sunitinib N-Oxide

Sunitinib N-Oxide

Cat. No.: ANT-SNB-03
CAS: 356068-99-0
Mol. Formula: C₂₂H₂₇FN₄O₃
Mol. Weight: 414.47